Agenda

March 5, 2021

Program is based on a minimum of 25% of time allowed for questions and answers.

8:30 – 8:45 am Self-guided Orientation to Online Platform
8:45 – 9:00 am WELCOME & INTRODUCTIONS
Dr. Shiva Jayaraman (Chair)
Unity Health
9:00 – 9:55 am Update on HCC Management
Dr. Ghassan Abou-Alfa
Memorial Sloan Kettering
10:00 – 10:55 am Best Neoadjuvant Strategy for Resectable Pancreas Cancer
Dr. Matthew Katz
MD Anderson
11:00 – 11:15 am BREAK
11:15am – 12:10 pm Gastroesophageal and Gastric Cancer Management
Dr. Yelena Y. Janjigian
Memorial Sloan Kettering
12:15 – 12:45 pm Tumor Board: Painless Jaundice NYD
Participants will be asked to use polling questions to choose answers in the case. Participants will be able to ask questions during case discussions.
 

Moderator: Suneil Khanna

Dr. Elena Elimova
Medical Oncologist
Princess Margaret Cancer Centre

Dr. Shiva Jayaraman
HPB Surgeon
Unity Health

Dr. Chirag Patel
Radiologist
Sunnybrook Health Sciences

Dr. Sylvia Ng
Radiation Oncologist
Sunnybrook Health Sciences

Dr. Corwyn Rowsell
Pathologist
Unity Health

Dr. Elaine Yeung
Gastroenterologist
Scarborough Health Network

12:50 – 1:30pm Multidisciplinary Session:
Oncology Biosimilar Implementation
Practical Considerations for Cancer Clinics

Moderator: Mark Pasetka, BSc, BScPharm, PharmD, RPh
Flay Charbonneau, BSc Pharm, RPH
Manager, Odette Cancer Centre Pharmacy
Learning Objectives:
1. To articulate the principles behind biosimilar implementation.
2. To discuss the logistical challenges of introducing biosimilars to the cancer clinic.
3. To describe metrics that may be used to evaluate biosimilar implementation.
1:30 – 1:40 pm SUMMARY & CLOSING
Dr. Shiva Jayaraman (Chair)